Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

Phase 3

Terminated

• Conditions: Anemia

• Registration Number: NCT00083486
• Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Brief Summary

The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-02
• Study First Submitted: 2004-05-24
• Study First Submitted QC: 2004-05-26
• Study First Posted: 2004-05-27
• Study Completion: 2004-10
• Status Verified: 2011-04
• Last Update Submitted: 2011-04-25
• Last Update Posted: 2011-04-27

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Body weight >/=99 lbs
• ECOG 0-2
• Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy
• Screening hemoglobin level of </=11.0 g/dL for men or </=10.0 for women

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (12)

Southern Illinois Hematology; 🇺🇸 Centralia, Illinois, United States

Spalding Oncology Services; 🇺🇸 Griffin, Georgia, United States

NorthEast Urology Research; 🇺🇸 Concord, North Carolina, United States

Slocum-Dickson Medical Group, PC; 🇺🇸 New Hartford, New York, United States

Charleston Hematology Oncology; 🇺🇸 Charleston, South Carolina, United States

BioLab Research; 🇺🇸 Rockville, Maryland, United States

Volunteer Research Group; 🇺🇸 Knoxville, Tennessee, United States

Heritage Physician Group-Oncology; 🇺🇸 Hot Springs, Arkansas, United States

Mid Ohio Oncology Hematology; 🇺🇸 Columbus, Ohio, United States

Drexel University College of Medicine; 🇺🇸 Philadelphia, Pennsylvania, United States

Caroline Cancer Center; 🇺🇸 Aiken, South Carolina, United States

Charleston Cancer Care; 🇺🇸 Charleston, South Carolina, United States